Massachusetts Financial Services Co. MA Has $42.25 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Massachusetts Financial Services Co. MA raised its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 478,104 shares of the company's stock after buying an additional 39,759 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.55% of HealthEquity worth $42,250,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $78,107,000. Norges Bank bought a new position in shares of HealthEquity during the 4th quarter worth approximately $74,701,000. Raymond James Financial Inc. bought a new position in shares of HealthEquity during the 4th quarter worth approximately $45,728,000. Iron Triangle Partners LP bought a new position in shares of HealthEquity during the 4th quarter worth approximately $32,202,000. Finally, Artisan Partners Limited Partnership bought a new position in shares of HealthEquity during the 4th quarter worth approximately $24,568,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 291,744 shares of company stock worth $32,705,007. Corporate insiders own 1.50% of the company's stock.

HealthEquity Stock Down 0.6%

Shares of HealthEquity stock traded down $0.62 during trading on Monday, reaching $97.08. The stock had a trading volume of 693,526 shares, compared to its average volume of 870,969. The company has a market capitalization of $8.39 billion, a price-to-earnings ratio of 37.01, a P/E/G ratio of 1.51 and a beta of 0.49. The stock has a fifty day moving average price of $101.65 and a two-hundred day moving average price of $98.49. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same period in the previous year, the company posted $0.80 earnings per share. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on HQY shares. JMP Securities raised their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada lifted their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.